Literature DB >> 9527782

Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis.

J W Benbow1, E L Bernberg, A Korda, J R Mead.   

Abstract

The efficacy of a series of dinitroaniline herbicide derivatives for the treatment of Cryptosporidium parvum infections has been studied. The lead compounds oryzalin (compound 1) and trifluralin (compound 2) have low water solubility (<3 ppm) which was alleged to be a major contributor to their poor pharmacokinetic availability. Derivatives of compounds 1 and 2 were synthesized. In these derivatives the functionality at the C-1 amine position or the C-4 position was substituted with groups with various hydrophilicities to determine if a direct relation existed between water solubility and overall activity. The chlorinated precursors of these derivatives were also examined and were found to be less active in the C. parvum assays, a result in direct contrast to earlier work with Leishmania. Enhanced water solubility alone did not overcome the drug availability problem; however, several candidates with similar activities but with toxicities lower than those of the lead compounds were produced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527782      PMCID: PMC105410          DOI: 10.1128/AAC.42.2.339

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Activity of azithromycin against cryptosporidia in immunosuppressed rats.

Authors:  J E Rehg
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor.

Authors:  P Heinz-Erian; U Kessler; B Funk; P Gais; W Kiess
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

3.  New type of adhesive specificity revealed by oligosaccharide probes in Escherichia coli from patients with urinary tract infection.

Authors:  I J Rosenstein; M S Stoll; T Mizuochi; R A Childs; E F Hounsell; T Feizi
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

4.  Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin.

Authors:  M M Chan; D Fong
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

5.  Anticryptosporidial activity is associated with specific sulfonamides in immunosuppressed rats.

Authors:  J E Rehg
Journal:  J Parasitol       Date:  1991-04       Impact factor: 1.276

6.  Effect of the anti-microtubule drug oryzalin on growth and differentiation of the parasitic protozoan Leishmania mexicana.

Authors:  M M Chan; R E Triemer; D Fong
Journal:  Differentiation       Date:  1991-02       Impact factor: 3.880

7.  A chemiluminescence immunoassay for evaluation of Cryptosporidium parvum growth in vitro.

Authors:  X You; M J Arrowood; M Lejkowski; L Xie; R F Schinazi; J R Mead
Journal:  FEMS Microbiol Lett       Date:  1996-03-01       Impact factor: 2.742

Review 8.  Antiparasitic agents.

Authors:  J E Rosenblatt
Journal:  Mayo Clin Proc       Date:  1992-03       Impact factor: 7.616

Review 9.  Prophylaxis of opportunistic infections in patients with HIV infection.

Authors:  A Carr; R Penny; D A Cooper
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993

10.  Effects of enteric parasitoses and HIV infection upon small intestinal structure and function in patients with AIDS.

Authors:  D P Kotler; S Reka; K Chow; J M Orenstein
Journal:  J Clin Gastroenterol       Date:  1993-01       Impact factor: 3.062

View more
  10 in total

Review 1.  Cytoskeleton of apicomplexan parasites.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

2.  SPM1 stabilizes subpellicular microtubules in Toxoplasma gondii.

Authors:  Johnson Q Tran; Catherine Li; Alice Chyan; Lawton Chung; Naomi S Morrissette
Journal:  Eukaryot Cell       Date:  2011-10-21

3.  Synthesis and evaluation of oryzalin analogs against Toxoplasma gondii.

Authors:  Molla M Endeshaw; Catherine Li; Jessica de Leon; Ni Yao; Kirk Latibeaudiere; Kokku Premalatha; Naomi Morrissette; Karl A Werbovetz
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

4.  Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.

Authors:  Christopher Ma; Johnson Tran; Frank Gu; Roxanna Ochoa; Catherine Li; David Sept; Karl Werbovetz; Naomi Morrissette
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

5.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  Heterogeneity in the sensitivity of microtubules of Giardia lamblia to the herbicide oryzalin.

Authors:  Letícia L Terra; Loraine Campanati; Wanderley De Souza
Journal:  Parasitol Res       Date:  2010-04-20       Impact factor: 2.289

Review 7.  Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective.

Authors:  Annunziata Giangaspero; Federica Berrilli; Olga Brandonisio
Journal:  Parasitol Res       Date:  2007-06-26       Impact factor: 2.289

8.  Modifications of DCDHF single molecule fluorophores to impart water solubility.

Authors:  Hui Wang; Zhikuan Lu; Samuel J Lord; W E Moerner; Robert J Twieg
Journal:  Tetrahedron Lett       Date:  2007-05-07       Impact factor: 2.415

9.  Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.

Authors:  Rati Lama; Ranjodh Sandhu; Bo Zhong; Bibo Li; Bin Su
Journal:  Bioorg Med Chem Lett       Date:  2012-07-14       Impact factor: 2.823

10.  A Simple and Rapid LC-MS/MS Method for the Determination of BMCL26 a Novel Anti-Parasitic Agent in Rat Plasma.

Authors:  Ramakrishna R Voggu; Xiang Zhou; Bin Su; Baochuan Guo
Journal:  J Anal Bioanal Tech       Date:  2015-08-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.